The GBLX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GBLX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GBLX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GBLX Detailed Price Forecast - CNN Money||View GBLX Detailed Summary - Google Finance|
|View GBLX Detailed Summary - Yahoo! Finance||View GBLX Stock Research & Analysis - Zacks.com|
|View GBLX Trends & Analysis - Trade-Ideas||View GBLX Major Holders - Barrons|
|View GBLX Call Transcripts - NASDAQ||View GBLX Breaking News & Analysis - Seeking Alpha|
|View GBLX Annual Report - CompanySpotlight.com||View GBLX OTC Short Report - OTCShortReport.com|
|View GBLX Fundamentals - TradeKing||View GBLX SEC Filings - Bar Chart|
|View Historical Prices for GBLX - The WSJ||View Performance/Total Return for GBLX - Morningstar|
|View the Analyst Estimates for GBLX - MarketWatch||View the Earnings History for GBLX - CNBC|
|View the GBLX Earnings - StockMarketWatch||View GBLX Buy or Sell Recommendations - MacroAxis|
|View the GBLX Bullish Patterns - American Bulls||View GBLX Short Pain Metrics - ShortPainBot.com|
|View GBLX Stock Mentions - StockTwits||View GBLX Stock Mentions - PennyStockTweets|
|View GBLX Stock Mentions - Twitter||View GBLX Investment Forum News - Investor Hub|
|View GBLX Stock Mentions - Yahoo! Message Board||View GBLX Stock Mentions - Seeking Alpha|
|View Insider Transactions for GBLX - SECform4.com||View Insider Transactions for GBLX - Insider Cow|
|View GBLX Major Holdings Summary - CNBC||View Insider Disclosure for GBLX - OTC Markets|
|View Insider Transactions for GBLX - Yahoo! Finance||View Institutional Holdings for GBLX - NASDAQ|
|View GBLX Stock Insight & Charts - FinViz.com||View GBLX Investment Charts - StockCharts.com|
|View GBLX Stock Overview & Charts - BarChart||View GBLX User Generated Charts - Trading View|
GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations
Posted on Friday December 20, 2019
GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for their Parkinson's disease ("PD") formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of the National Research Council (NRC) in Halifax, Nova Scotia, CANADA. GB Sciences' PD formulations were able to reduce behavioral changes associated with the loss of dopamine-producing neurons, which underlies the pathology of Parkinson's disease in the animal model. Our final phase of testing will study the mechanism of action for these promising formulations, which could potentially help patients with this debilitating disease. The combined direct and indirect costs associated with Parkinson's disease are estimated at $52 billion in the U.S. alone.
GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain
Posted on Thursday December 05, 2019
LAS VEGAS , Dec. 5, 2019 /CNW/ -- GB Sciences, Inc. (GBLX) announced the execution of a Binding Letter of Intent for the Sale of 75% of its membership interests in the Company's Las Vegas, Nevada cultivation and production operation. This transaction will significantly reduce the Company's operating expenses, generate near-term working capital, and provide ongoing cashflow to enable the Company to focus solely on its biopharmaceutical and wellness assets. The transaction is the next step in the Company's exit from cannabis cultivation and production.
GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement
Posted on Monday November 18, 2019
The Sale, Which Immediately Eliminates Substantial Cash Obligations and Operating Expenses, Is Collateralized by Wellcana Plus's Interest in GB Sciences Louisiana. LAS VEGAS, Nov. 18, 2019 /PRNewswire/ -- GB Sciences, Inc. (GBLX) completed the sale on November 15, 2019 of its 50% membership interest in GB Sciences Louisiana, LLC to Wellcana Plus, LLC, an affiliate of Wellcana Group, LLC who owns the other 50% interest. The sale immediately eliminates current cash obligations due from GB Sciences as well as the Company's share of operating expenses going forward.
GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine
Posted on Wednesday October 09, 2019
LAS VEGAS , Oct. 9, 2019 /CNW/ -- GB Sciences, Inc. (GBLX) is featured in the October 2019 edition of the Marijuana Business Magazine. Dr. Andrea Small-Howard , GB Sciences' Chief Science Officer and Director, explains why GB Sciences is well-positioned to provide research-supported product formulations for both market segments.